Committee for Orphan Medicinal Products (COMP): 6-8 October 2026

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
EventHumanRare diseases

Slovak is available via eTranslation, the European Commission's machine translation service.

Translate to Slovak | Important information about machine translation

Dátum

- ,

Umiestnenie

European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the COMP Meeting 6-8 October 2026

Draft

English (EN) (487.1 KB - XLSX)

Prvýkrát uverejnené:
Zobraziť

Share this page